New technology crosses blood-brain barrier to traet cancer
A novel drug delivery system has been developed by scientists from the USA, Canada and France which can cross the blood-brain barrier to reach the cancer cells in the brain and kill them. Currently, the technology is in Phase I of its clinical trial. At present, not even 5 % of drugs can cross this barrier. The non-invasive tool is being developed by Angiochem Inc.
- Study shows Avastin can play critical role in treatment of brain cancer
- ImmunoCellular’s Cancer Vaccine Demonstrates Immune Response Against Brain Cancer
- Blood Scanner That Detects Even Faint Indicators Of Cancer Developed By Stanford Researchers
- Aggressive Brain Cancer Driven By Two Collaborating Genes, Study
